The Evaluation of Belimumab in Myasthenia Gravis (MG)
NCT01480596
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Myasthaenia Gravis
Interventions
BIOLOGICAL:
Belimumab
OTHER:
Placebo
Sponsor
GlaxoSmithKline